Within the last century there have been three influenza pandemics, each strain specific: H1N1 in 1918; H2N2 in 1957; and H3N2 in 1968. The company's research team analyzed the amino acid sequences of the reported strains and found that with each pandemic there was a strain-specific increase in the Replikin Count™ peptide quantities within the strain, followed by a decrease in Replikin Count™ peptide quantities and several years later a rebound increase associated in each case with a strain-specific rebound epidemic. The x axis of Figure 1 below shows the year and the y axis shows the Replikin Count™ peptide quantities per 100 amino acids. Note that within Figure 1, there is a separate graph for each pandemic.
Boston, November 27, 2009 - Biotech firm Replikins Ltd., which has analyzed the H1N1 virus' genomic data from the 1918 pandemic through the prediction, outbreak, and progress of the current H1N1 pandemic, today issued its latest biochemical analysis of the virus... Read more
Boston, October 19, 2009 - There is increasing evidence that, with best intent, current biological technology cannot supply the world's six billion humans, and animal populations, with vaccines against emerging diseases at a rate that can contend with a disease's rapid appearance and change... Read more